Several AMPs show broad and simultaneous activities against bacteria, fungi, viruses, and in case of infection with multiple microorganisms, one AMP could be efficient to overcome this issue. |
AMPs are susceptible to proteolytic degradation, which leads to the loss of biological activity. |
Natural AMPs are already found in high doses at the site of infection. |
Some AMPs can be toxic to mammal cells at high concentrations. |
Some AMPs have wound-healing and angiogenesis promotion properties, which are essential in case of hard-to-heal and infected wounds, such as diabetes and foot ulcer. |
AMPs can induce hypersensitivity reactions after application. |
AMPs show as well anti-inflammatory properties by modulating immune cytokines, which are responsible for the inflammatory response. |
AMPs can be influenced by pH variation and at low concentration of salt can be destabilized, leading to loss of activity. |
AMPs exhibit therapeutic antimicrobial activity at extremely low concentrations in the microscale and sometimes nanoscale range. |
AMP’s production and purification costs are high. |
Resistance to AMPs is very low and only in a limited number of AMPs. |
|
AMPs showed to be time-efficient; some AMPs can act within a few seconds to a few minutes. |
|
AMPs inhibit biofilm formation, which is especially important to prevent bacterial growth on medical devices. |
|
AMPs show synergism when chemically coupled to polymers, encapsulated into different delivery systems or simultaneously applied with antimicrobial agents. |
|
AMPs can act synergistically with antibiotics. |
|